These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 34531366)

  • 1. GOLM1 suppresses autophagy-mediated anti-tumor immunity in hepatocellular carcinoma.
    Sui T; Wang X; Li L; Liu J; Qiao N; Duan L; Shi M; Huang J; Yang H; Cheng G
    Signal Transduct Target Ther; 2021 Sep; 6(1):335. PubMed ID: 34531366
    [No Abstract]   [Full Text] [Related]  

  • 2. GOLM1 exacerbates CD8
    Chen J; Lin Z; Liu L; Zhang R; Geng Y; Fan M; Zhu W; Lu M; Lu L; Jia H; Zhang J; Qin LX
    Signal Transduct Target Ther; 2021 Nov; 6(1):397. PubMed ID: 34795203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemerin has a protective role in hepatocellular carcinoma by inhibiting the expression of IL-6 and GM-CSF and MDSC accumulation.
    Lin Y; Yang X; Liu W; Li B; Yin W; Shi Y; He R
    Oncogene; 2017 Jun; 36(25):3599-3608. PubMed ID: 28166197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver fibrosis promotes immune escape in hepatocellular carcinoma via GOLM1-mediated PD-L1 upregulation.
    Ke MY; Xu T; Fang Y; Ye YP; Li ZJ; Ren FG; Lu SY; Zhang XF; Wu RQ; Lv Y; Dong J
    Cancer Lett; 2021 Aug; 513():14-25. PubMed ID: 33992711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The polymorphism rs975484 in the protein arginine methyltransferase 1 gene modulates expression of immune checkpoint genes in hepatocellular carcinoma.
    Schonfeld M; Zhao J; Komatz A; Weinman SA; Tikhanovich I
    J Biol Chem; 2020 May; 295(20):7126-7137. PubMed ID: 32245889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β-Arrestin1 enhances hepatocellular carcinogenesis through inflammation-mediated Akt signalling.
    Yang Y; Guo Y; Tan S; Ke B; Tao J; Liu H; Jiang J; Chen J; Chen G; Wu B
    Nat Commun; 2015 Jun; 6():7369. PubMed ID: 26077142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-15a/16-1 Prevents Hepatocellular Carcinoma by Disrupting the Communication Between Kupffer Cells and Regulatory T Cells.
    Liu N; Chang CW; Steer CJ; Wang XW; Song G
    Gastroenterology; 2022 Feb; 162(2):575-589. PubMed ID: 34678217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholesterol suppresses GOLM1-dependent selective autophagy of RTKs in hepatocellular carcinoma.
    Shao WQ; Zhu WW; Luo MJ; Fan MH; Li Q; Wang SH; Lin ZF; Zhao J; Zheng Y; Dong QZ; Lu L; Jia HL; Zhang JB; Lu M; Chen JH; Qin LX
    Cell Rep; 2022 Apr; 39(3):110712. PubMed ID: 35443161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo imaging of an inducible oncogenic tumor antigen visualizes tumor progression and predicts CTL tolerance.
    Buschow C; Charo J; Anders K; Loddenkemper C; Jukica A; Alsamah W; Perez C; Willimsky G; Blankenstein T
    J Immunol; 2010 Mar; 184(6):2930-8. PubMed ID: 20142365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-12 gene therapy is an effective therapeutic strategy for hepatocellular carcinoma in immunosuppressed mice.
    Harada N; Shimada M; Okano S; Suehiro T; Soejima Y; Tomita Y; Maehara Y
    J Immunol; 2004 Dec; 173(11):6635-44. PubMed ID: 15557154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [DNA vaccine encoding alpha-fetoprotein with fused ornithine decarboxylase degradation signal significantly suppresses hepatocellular carcinoma growth in mice].
    Morozov AV; Morozov VA; Astakhova TM; Timofeev AV; Karpov VL
    Mol Biol (Mosk); 2012; 46(3):434-51. PubMed ID: 22888633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD137-mediated pathogenesis from chronic hepatitis to hepatocellular carcinoma in hepatitis B virus-transgenic mice.
    Wang J; Zhao W; Cheng L; Guo M; Li D; Li X; Tan Y; Ma S; Li S; Yang Y; Chen L; Wang S
    J Immunol; 2010 Dec; 185(12):7654-62. PubMed ID: 21059892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioimmunodetection and autoradiographic localization of monoclonal antibody against human hepatocellular carcinoma in xenografts.
    Ji YY; Liu YF; Chen ZN
    Cancer; 1992 Apr; 69(8):2055-9. PubMed ID: 1311979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. STK4 regulates TLR pathways and protects against chronic inflammation-related hepatocellular carcinoma.
    Li W; Xiao J; Zhou X; Xu M; Hu C; Xu X; Lu Y; Liu C; Xue S; Nie L; Zhang H; Li Z; Zhang Y; Ji F; Hui L; Tao W; Wei B; Wang H
    J Clin Invest; 2015 Nov; 125(11):4239-54. PubMed ID: 26457732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma.
    Li X; Yao W; Yuan Y; Chen P; Li B; Li J; Chu R; Song H; Xie D; Jiang X; Wang H
    Gut; 2017 Jan; 66(1):157-167. PubMed ID: 26452628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inducing oral immune regulation of hepatitis B virus envelope proteins suppresses the growth of hepatocellular carcinoma in mice.
    Gotsman I; Alper R; Klein A; Rabbani E; Engelhardt D; Ilan Y
    Cancer; 2002 Jan; 94(2):406-14. PubMed ID: 11900226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenovirus-mediated gene transfer into tumors: evaluation of direct readministration of an adenoviral vector into subcutaneous tumors of immunocompetent mice.
    Nagao S; Kuriyama S; Okuda H; Tominaga K; Nakatani T; Tsujinoue H; Yoshiji H; Fukui H
    Int J Oncol; 2001 Jan; 18(1):57-65. PubMed ID: 11115539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulating immunity and inhibiting tumor growth by the recombinant peptide sPD-1-CH50.
    Qiu H; Liu S; Xie C; Long J; Feng Z
    Anticancer Res; 2009 Dec; 29(12):5089-94. PubMed ID: 20044621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted gene transfer to hepatocellular carcinoma cells in vitro using a novel monoclonal antibody-based gene delivery system.
    Mohr L; Schauer JI; Boutin RH; Moradpour D; Wands JR
    Hepatology; 1999 Jan; 29(1):82-9. PubMed ID: 9862854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-125b reverses oxaliplatin resistance in hepatocellular carcinoma by negatively regulating EVA1A mediated autophagy.
    Ren WW; Li DD; Chen X; Li XL; He YP; Guo LH; Liu LN; Sun LP; Zhang XP
    Cell Death Dis; 2018 May; 9(5):547. PubMed ID: 29749374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.